Exos Asset Management’s Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 WPCB.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-7,160
Closed -$7K 392
2021
Q4
$7K Hold
7,160
﹤0.01% 354
2021
Q3
$7K Buy
+7,160
New +$8.41K ﹤0.01% 439

Other funds holding WPCB.WS

Exos Asset Management's WPCB.WS Position: Q1 2022 in Review

Exos Asset Management sold out of Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (WPCB.WS) in Q1 2022, closing a stake of 7,160 shares — an estimated $7K sold.

Exos Asset Management first reported a position in WPCB.WS in Q3 2021 and held it in 2 quarters. The position peaked at $7K in Q4 2021. 51 funds tracked by Wall St. Rank hold WPCB.WS as of Q1 2022.

  • Exos Asset Management reported no remaining Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q1 2022 after selling out during the quarter.
  • Exos Asset Management sold 7,160 Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q1 2022, an estimated $7K.
  • Exos Asset Management first reported a position in Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q3 2021 and held it in 2 quarters.
  • Exos Asset Management's Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $7K in Q4 2021.
  • 51 funds tracked by Wall St. Rank held Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q1 2022.

Based on Exos Asset Management's 13F filing for Q1 2022, filed 13 Apr 2022.